Fundraising Fox
Secura Bio
San Diego, US · Founded 2019 · Delaware corporation
Find your way into Secura Bio
Sign up to see every warm intro you have to Secura Bio
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Secura Bio team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Secura Bio develops and commercializes oncology therapies for difficult-to-treat patient populations. The company leverages extensive experience in clinical development and market launch to bring life-prolonging cancer medicines to patients.
Founders & leadership
JL
Joseph LimberExecutive
BL
Brett LundChief Operating Officer & Chief Legal Officer2018–2024He brings experience in corporate law, business development, and biotechnology licensing from roles at international law firms and public companies, including expertise in technology transfer, financing, and international transactions.
MS
Mark SpringExecutive
JE
Juan EstruchExecutive
Reported raises · per SEC filings
Form D private placements$50M disclosed across 1 round · 2019
▶$50MraisedApr 2019 · 2 investors · PharmaceuticalsRule 506(b)
▶$50MraisedApr 2019 · 2 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Joseph LimberExecutive Officer, Director
- Brett LundExecutive Officer, Director
- Mark SpringExecutive Officer, Director
- Juan EstruchExecutive Officer
- Offering amount
- $90M
- Amount sold
- $50M
- Minimum investment
- $10M
- First sale
- Mar 2019
- Incorporated
- Corporation, Delaware, 2019
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 3
Curi BioCuri Bio provides a preclinical drug development platform combining 3D human tissue models of disease (cardiac and skeletal muscle), biosystems for functional analysis, and AI/ML-based insights to assess drug safety, efficacy, and potency. It serves pharmaceutical and biotech R&D teams working on drug discovery.
Day One BiopharmaceuticalsDay One is a biopharmaceutical company that develops first- or best-in-class targeted medicines for children and adults with life-threatening diseases, with a focus on cancers such as pediatric brain tumors. Founded in 2018, it received its first FDA approval in 2024 for a pediatric brain tumor treatment.
IQVIAIQVIA is a healthcare data and technology company that supports life sciences organizations in research, clinical development, and commercialization of medicines and medical solutions.
Companies working in the same space as Secura Bio.
Frequently asked questions
- What does Secura Bio do?
- Secura Bio develops and commercializes oncology therapies for difficult-to-treat patient populations. The company leverages extensive experience in clinical development and market launch to bring life-prolonging cancer medicines to patients.
- How much funding has Secura Bio raised?
- Secura Bio has disclosed $50M raised across 1 round.
- Where is Secura Bio headquartered?
- Secura Bio is headquartered in San Diego, US.